| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $53.2M | -9.4% |
| Cost of Revenue | $63.6M | +10.0% |
| R&D Expense | $31.9M | +57.6% |
| SG&A Expense | $81.6M | +2.0% |
| Operating Income | -$187.4M | -88.4% |
| Pre-tax Income | -$180.6M | -146.2% |
| Income Tax | -$810K | +93.9% |
| Net Income | -$179.8M | -199.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $62.8M | -78.1% |
| Accounts Receivable | $18.0M | +4.9% |
| Inventory | $32.7M | +33.2% |
| Current Assets | $125.1M | -63.3% |
| Total Assets | $712.3M | -15.1% |
| Current Liabilities | $25.3M | -41.8% |
| Long-term Debt | $298.3M | +9.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$61.8M | +1.8% |
| Capital Expenditures | $164.5M | -11.3% |
| Investing Cash Flow | -$182.5M | +45.7% |
| Financing Cash Flow | $21.8M | -92.9% |
| Free Cash Flow | -$226.3M | +8.9% |
| Total Liabilities |
| $334.7M |
| -1.1% |
| Stockholders' Equity | $377.6M | -24.5% |